Fierce Pharma
MAY 30, 2023
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit zbecker Tue, 05/30/2023 - 10:24
Pharmaceutical Technology
MAY 30, 2023
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion is intended for the prevention of Covid-19 resulting from SARS-CoV-2 infection in individuals aged 18 years and above. The authorisation allows the distribution of the vaccine in Scotland, Wales and England.
Fierce Pharma
MAY 30, 2023
After price cuts, Eli Lilly inks $13.
MedCity News
MAY 30, 2023
Employers have a responsibility to support the food as medicine movement and help employees who are food insecure, said Jay Bhatt, managing director of Deloitte Services and managing director of the Center for Health Solutions and Health Equity Institute. He made these comments last week at the MedCity INVEST conference in Chicago.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Fierce Pharma
MAY 30, 2023
Lexicon finally scores FDA nod for heart failure drug Inpefa kdunleavy Tue, 05/30/2023 - 05:46
Pharmaceutical Technology
MAY 30, 2023
According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. Lecanemab by Eisai Co Ltd, a monoclonal antibody therapy marketed for Alzheimer’s disease, is predicted to achieve the most significant commercial debut.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MAY 30, 2023
In addition to reducing workload, NLP and ambient voice technology can also improve the quality of care that clinicians provide. By analyzing EHRs and other patient data, NLP algorithms can identify potential health risk factors and recommend preventative measures.
Fierce Pharma
MAY 30, 2023
With court's blessing, billionaire Sackler family awarded legal protections in Purdue's $6B settlement zbecker Tue, 05/30/2023 - 15:41
MedCity News
MAY 30, 2023
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach a specific subset of patients, enabling it to stand apart from rival medicines from AstraZeneca and partners Eli Lilly and Boehringer Ingelheim.
PharmExec
MAY 30, 2023
Inpefa to support multiple cardiovascular issues.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaTimes
MAY 30, 2023
The EMA's human medicines committee concluded that the benefits of Adakveo did not outweigh its risks
Pharmaceutical Technology
MAY 30, 2023
Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases] for its gene therapy AMP-201. The company will receive substantial funding to advance AAV-ColQ gene therapy. AMP-201 addresses the severe congenital myasthenic syndrome (CMS) caused by collagen Q (ColQ) deficiency.
MedCity News
MAY 30, 2023
A group of federal agencies recently released an updated set of guidelines to help healthcare organizations protect themselves from ransomware attacks and the data breaches that often follow. The guidance lays out best practices to prevent the six major ways that bad actors gain access to providers’ systems, which include compromised credentials and phishing.
European Pharmaceutical Review
MAY 30, 2023
The European Commission (EC) has granted a marketing authorisation for EPYSQLI , a biosimilar to Soliris (eculizumab) for adults and children patients with paroxysmal nocturnal haemoglobinuria (PNH). “The approval of EPYSQLI , Samsung Bioepis’ first haematology biosimilar, reflects our ongoing endeavours to introduce more treatment options for PNH patients in Europe,” stated Byoungin Jung, Vice President and Regulatory Affairs Team Leader at Samsung Bioepis.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Referral MD
MAY 30, 2023
Photo by Marek Studzinski on Unsplash The medical billing process can be a tedious, lengthy, and complex one. This can leave healthcare practitioners struggling to stay afloat financially. Can a healthcare practice increase revenue by improving its medical billing process? A reliable medical billing service or software can help reduce backlogs and increase revenue.
MedCity News
MAY 30, 2023
Marstacimab, a Pfizer drug for both hemophilia A and B, met the main goal of a Phase 3 study and the company now plans to discuss the data with regulators. The Pfizer drug could beat to the market a Novo Nordisk drug that addresses the same novel target.
PharmaTimes
MAY 30, 2023
The drug has already been approved for this indication in the EU, with regulatory reviews continuing elsewhere including in the US
MedCity News
MAY 30, 2023
Global funding for digital health companies finally stabilized in Q1 of this year. The sector raised $3.4 billion — this marks the first time the digital health world didn’t experience a quarter-over-quarter funding decline since Q4 of 2021. By holding steady, digital health startups defied the dwindling fundraising totals seen across the broader venture capital landscape, where funding dropped by 13% quarter-over-quarter.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Clarify Health
MAY 30, 2023
Addressing the mental health crisis in the United States is a complex undertaking, due to multiple factors contributing to prevalence and severity of several conditions. Recent findings from the Clarify Health Institute highlight these growing problems and speak to a need for action to combat this crisis. According to its most recent research brief, “The Kids Are Not Alright: Mental Health Utilization Among Children and Young Adults, 2016-2022,” hospital admissions for mental illnes
MedCity News
MAY 30, 2023
Carrum Health’s $45 million funding round was led by OMERS Growth Equity and included participation from Revelation Partners, Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. It brings the company’s total financing to about $96 million.
Medgadget
MAY 30, 2023
Researchers at MIT have developed smart sutures with a hydrogel coating that contains sensing and drug delivery components, and could even be used to implant therapeutic cells. The sutures are made using pig tissues that have been decellularized with detergents to reduce the possibility that they could provoke an immune reaction. The surrounding hydrogel layer contains microparticles that can release peptides when enzymes involved in inflammation are present, and other microparticles that allow
PharmaTech
MAY 30, 2023
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
Medgadget
MAY 30, 2023
Researchers at UMass Chan Medical School have developed a small interfering RNA (siRNA) technology that is stable enough for inhalation into the lungs, where it can potentially treat diseases as diverse as asthma, pulmonary fibrosis, and viral infections such as COVID-19. siRNA is not typically stable enough to survive for long in the lungs, but the researchers chemically modified the constituent nucleotides to stabilize the molecules and help them to evade immune destruction.
MedReps
MAY 30, 2023
In order for teams to work together more effectively, each person involved needs to have respect for the others in the group. This is true in many different settings, including those who work in medical sales. For a medical sales team to become a high-performing one, they first need to make sure there’s a long-standing tradition of psychological safety involved for everyone in the group.
PharmaVoice
MAY 30, 2023
Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.
Clarivate
MAY 30, 2023
As the business value of intellectual property (IP) continues to grow, the need to manage IP as a strategic asset is greater than ever. As of 2018, intangible assets accounted for 84% of market capitalization for S&P 500 companies , compared to just 12% four decades ago. While 95% of senior corporate decision makers believe these intangible assets predict future strength , many organizations still fall short in their strategic IP management.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MAY 30, 2023
Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.
PharmaTech
MAY 30, 2023
Webinar Date/Time: Friday, June 23, 2023 at 11am EDT | 10am CDT | 8am PD
Spotio
MAY 30, 2023
The solar industry continues to grow, as does the competition to acquire new customers. Of course, the only way to acquire new customers is to first generate quality solar leads. It’s not always easy, but it’s far from impossible. We’re about to teach you exactly how to get solar leads for your business in 2023 using 12 proven strategies.
PharmaTech
MAY 30, 2023
Webinar Date/Time: Wed, Jun 21, 2023 2:00 PM EDT
Advertiser: ZoomInfo
Sales and marketing leaders have reached a tipping point when it comes to using intent data — and they’re not looking back. More than half of all B2B marketers are already using intent data to increase sales, and Gartner predicts this figure will grow to 70 percent. The reason is clear: intent can provide you with massive amounts of data that reveal sales opportunities earlier than ever before.
Expert insights. Personalized for you.
268 
Let's personalize your content